Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $118.51 | $24.23 | 389.17% | 223.60x | 56.40x | 15.03x | 18.15x | 1.62x | $106.92M | 0.86% | $705.78M | 6.70 | $12.71B | 1,620.03 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.27 | $8.28 | 217.40% | 125.10x | 58.73x | 7.39x | 14.97x | 1.07x | $39.15M | 1.14% | $220.58M | 1.69 | $3.38B | 74.50 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $249.59 | $81.09 | 207.79% | 40.92x | 37.01x | 6.94x | 24.66x | 1.41x | $793.95M | 2.38% | $1.35B | 10.14 | $34.68B | 29.40 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $75.34 | $17.45 | 331.65% | 70.41x | 64.45x | 6.95x | 8.99x | 1.80x | $182.84M | 3.13% | $654.15M | 8.43 | $5.71B | 47.61 | ||
| KRYS | KRYSTAL BIOTECH INC | $344.96 | $84.61 | 307.69% | 41.71x | 44.19x | 23.13x | 7.51x | 2.23x | $257.78M | 2.53% | $1.36B | 46.03 | $9.79B | 41.97 | ||
| VCEL | VERICEL CORP | $39.30 | $8.06 | 387.78% | 81.88x | 70.22x | 6.55x | 5.44x | 2.01x | $61.66M | 3.07% | $370.04M | 7.25 | $1.98B | 44.94 | ||
| HALO | HALOZYME THERAPEUTICS INC | $115.22 | $71.71 | 60.67% | 32.37x | 12.76x | 8.12x | 91.10x | 0.62x | $806.22M | 5.97% | $143.54M | 1.22 | $15.06B | 20.96 | ||
| RPRX | ROYALTY PHARMA PLC | $58.29 | $36.46 | 59.87% | 31.01x | 10.66x | 10.23x | 3.43x | 0.63x | $2.92B | 11.27% | $9.79B | 21.99 | $41.67B | 35.43 | ||
| TGTX | TG THERAPEUTICS INC | $57.52 | $22.59 | 154.59% | 18.68x | 57.88x | 10.20x | 14.58x | 2.08x | $17.39M | 0.21% | $604.08M | 4.26 | $9.07B | 65.17 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.35 | $18.78 | 226.69% | 161.45x | 21.20x | 3.48x | 1.88x | 1.07x | $738.18M | 6.22% | $6.32B | 32.68 | $15.19B | 39.38 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.26 | $7.67 | 46.80% | 11.85x | 10.35x | 4.90x | 3.07x | 1.03x | $82.01M | 12.31% | $217.65M | 3.68 | $524.84M | 6.79 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $299.04 | $86.52 | 245.63% | 29.70x | 31.65x | 20.65x | 6.16x | 2.25x | $130.62M | 2.18% | $967.52M | 48.22 | $6.09B | 21.82 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $236.28 | $181.67 | 30.06% | 15.48x | 9.24x | 3.25x | 3.19x | 0.64x | $1.62B | 10.85% | $4.80B | 75.98 | $18.11B | 11.21 | ||
| MDXG | MIMEDX GROUP INC | $4.71 | $1.28 | 267.10% | 117.75x | -27.16x | 1.96x | 3.18x | 1.28x | $44.50M | 6.39% | $216.00M | 1.46 | $567.90M | 24.90 | ||
| ADMA | ADMA BIOLOGICS INC | $9.52 | $7.03 | 35.38% | 13.22x | 11.97x | 4.24x | 5.22x | 0.77x | $116.47M | 5.36% | $408.21M | 1.79 | $2.19B | 9.42 | ||
| EXEL | EXELIXIS INC | $57.95 | $30.24 | 91.64% | 17.61x | 17.52x | 5.97x | 7.79x | 1.16x | $1.17B | 8.07% | $1.84B | 7.35 | $14.24B | 13.09 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $522.38 | $149.52 | 249.37% | 30.14x | 27.29x | 10.53x | 6.54x | 2.26x | $3.80B | 2.86% | $20.25B | 79.81 | $128.24B | 23.30 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $796.02 | $431.24 | 84.59% | 18.98x | 14.19x | 5.27x | 2.58x | 1.00x | $3.76B | 4.60% | $31.71B | 308.48 | $82.21B | 14.30 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.16 | $30.33 | 35.72% | 13.11x | 9.87x | 2.48x | 2.40x | 0.78x | $354.90M | 14.88% | $999.24M | 17.25 | $2.00B | 7.15 | ||
| TECH | BIO-TECHNE CORP | $72.57 | $16.41 | 342.22% | 62.03x | 34.93x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.80 | ||
| UTHR | UNITED THERAPEUTICS CORP | $472.21 | $190.09 | 148.41% | 15.62x | 17.67x | 6.38x | 3.16x | 2.86x | $1.09B | 5.43% | $6.40B | 150.24 | $18.45B | 11.01 | ||
| VCYT | VERACYTE INC | $48.54 | $11.82 | 310.69% | 33.71x | 24.96x | 6.91x | 2.81x | 2.83x | $165.99M | 4.28% | $1.39B | 17.36 | $3.64B | 26.07 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.25 | $1.40 | -10.64% | 8.93x | -2.82x | 1.54x | 1.65x | 0.50x | $19.58M | 27.04% | $44.20M | 0.76 | $24.06M | 3.15 | ||
| INCY | INCYTE CORP | $124.44 | $59.37 | 109.61% | 15.33x | 35.10x | 4.28x | 3.98x | 1.72x | $1.92B | 7.70% | $6.34B | 31.66 | $21.27B | 10.29 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.